STERIS (NYSE:STE) Rating Reiterated by JMP Securities

JMP Securities restated their market outperform rating on shares of STERIS (NYSE:STE - Free Report) in a report released on Thursday, Benzinga reports. They currently have a $265.00 price objective on the medical equipment provider's stock.

Several other analysts have also issued reports on STE. KeyCorp started coverage on shares of STERIS in a research report on Tuesday, February 6th. They issued an overweight rating and a $253.00 price target on the stock. TheStreet raised STERIS from a c+ rating to a b rating in a report on Wednesday, February 7th. Stephens restated an overweight rating and set a $250.00 price objective on shares of STERIS in a research report on Friday, February 9th. StockNews.com lowered STERIS from a buy rating to a hold rating in a research note on Friday, May 3rd. Finally, Needham & Company LLC reissued a hold rating on shares of STERIS in a report on Friday, April 12th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, STERIS has an average rating of Hold and an average target price of $239.60.

STERIS Stock Performance

NYSE:STE traded up $15.95 during midday trading on Thursday, reaching $226.04. The stock had a trading volume of 926,048 shares, compared to its average volume of 475,059. The stock has a market capitalization of $22.34 billion, a P/E ratio of 39.59 and a beta of 0.81. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.43 and a quick ratio of 1.49. STERIS has a 1-year low of $187.07 and a 1-year high of $254.00. The firm's fifty day simple moving average is $217.02 and its 200-day simple moving average is $216.04.

STERIS (NYSE:STE - Get Free Report) last posted its quarterly earnings data on Wednesday, May 8th. The medical equipment provider reported $2.58 earnings per share for the quarter, topping the consensus estimate of $2.41 by $0.17. The business had revenue of $1.42 billion during the quarter, compared to analysts' expectations of $1.41 billion. STERIS had a return on equity of 13.67% and a net margin of 10.48%. The firm's revenue was up 10.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.30 EPS. On average, equities research analysts forecast that STERIS will post 8.67 EPS for the current fiscal year.

STERIS Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 26th. Shareholders of record on Wednesday, June 12th will be paid a dividend of $0.52 per share. The ex-dividend date of this dividend is Wednesday, June 12th. This represents a $2.08 annualized dividend and a yield of 0.92%. STERIS's dividend payout ratio is currently 36.43%.

Hedge Funds Weigh In On STERIS

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Global Retirement Partners LLC boosted its holdings in shares of STERIS by 9.4% in the 1st quarter. Global Retirement Partners LLC now owns 570 shares of the medical equipment provider's stock worth $128,000 after acquiring an additional 49 shares in the last quarter. First Hawaiian Bank increased its stake in shares of STERIS by 0.4% in the first quarter. First Hawaiian Bank now owns 13,857 shares of the medical equipment provider's stock valued at $3,115,000 after buying an additional 50 shares in the last quarter. Greenleaf Trust raised its holdings in shares of STERIS by 2.8% in the third quarter. Greenleaf Trust now owns 1,888 shares of the medical equipment provider's stock valued at $414,000 after buying an additional 51 shares during the last quarter. Park Edge Advisors LLC lifted its position in STERIS by 1.2% during the 4th quarter. Park Edge Advisors LLC now owns 4,409 shares of the medical equipment provider's stock worth $969,000 after buying an additional 51 shares in the last quarter. Finally, UMB Bank n.a. grew its holdings in STERIS by 7.8% during the 4th quarter. UMB Bank n.a. now owns 716 shares of the medical equipment provider's stock worth $157,000 after acquiring an additional 52 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.